John R. Pinion II
2017
In 2017, John R. Pinion II earned a total compensation of $1.9M as Chief Quality Officer and Executive Vice President of Translational Sciences at Ultragenyx Pharmaceutical, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $170,459 |
|---|---|
| Option Awards | $991,208 |
| Salary | $412,568 |
| Stock Awards | $308,603 |
| Other | $36,491 |
| Total | $1,919,329 |
Pinion received $991.2K in option awards, accounting for 52% of the total pay in 2017.
Pinion also received $170.5K in non-equity incentive plan, $412.6K in salary, $308.6K in stock awards and $36.5K in other compensation.
Rankings
In 2017, John R. Pinion II's compensation ranked 5,705th out of 14,666 executives tracked by ExecPay. In other words, Pinion earned more than 61.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,705 out of 14,666 | 61st |
Division Manufacturing | 2,071 out of 5,772 | 64th |
Major group Chemicals And Allied Products | 642 out of 2,075 | 69th |
Industry group Drugs | 494 out of 1,731 | 72nd |
Industry Pharmaceutical Preparations | 389 out of 1,333 | 71st |
Source: SEC filing on April 27, 2018.
Pinion's colleagues
We found five more compensation records of executives who worked with John R. Pinion II at Ultragenyx Pharmaceutical in 2017.
2017
Emil Kakkis
Ultragenyx Pharmaceutical
Chief Executive Officer
2017
Jayson Dallas
Ultragenyx Pharmaceutical
Chief Commercial Officer and Executive Vice President
2017
Shalini Sharp
Ultragenyx Pharmaceutical
Chief Financial Officer
2017
Thomas Kassberg
Ultragenyx Pharmaceutical
Chief Business Officers and Executive Vice President
2017
Karah Parschauer
Ultragenyx Pharmaceutical